The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Circulating Tumor Cells: Liquid Biopsy of Cancer
Open accessAbstract
BACKGROUND: The detection and molecular characterization of circulating tumor cells (CTCs) are one of the most active areas of translational cancer research, with >400 clinical studies having included CTCs as a biomarker. The aims of research on CTCs include (a) estimation of the risk for metastatic relapse or metastatic progression (prognostic information), (b) stratification and real-time monitoring of therapies, (c) identification of therapeutic targets and resistance mechanisms, and (d) understanding metastasis development in cancer patients. CONTENT: This review focuses on the technologies used for the enrichment and detection of CTCs. We outline and discuss the current technologies that are based on exploiting the physical and biological properties of CTCs. A number of innovative technologies to improve methods for CTC detection have recently been developed, including CTC microchips, filtration devices, quantitative reverse-transcription PCR assays, and automated microscopy systems. Molecular-characterization studies have indicated, however, that CTCs are very heterogeneous, a finding that underscores the need for multiplex approaches to capture all of the relevant CTC subsets. We therefore emphasize the current challenges of increasing the yield and detection of CTCs that have undergone an epithelial–mesenchymal transition. Increasing assay analytical sensitivity may lead, however, to a decrease in analytical specificity (e.g., through the detection of circulating normal epithelial cells). SUMMARY: A considerable number of promising CTC-detection techniques have been developed in recent years. The analytical specificity and clinical utility of these methods must be demonstrated in large prospective multicenter studies to reach the high level of evidence required for their introduction into clinical practice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
Mani, S. A., Guo, W., Liao, M.-J., Eaton, E. N., Ayyanan, A., Zhou, A. Y., Brooks, M., Reinhard, F., Zhang, C. C., Shipitsin, M., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.027 · Cited by 8,672
Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer
Cristofanilli, M., Budd, G. T., Ellis, M. J., Stopeck, A., Matera, J., Miller, M. C., Reuben, J. M., Doyle, G. V., Allard, W. J., Terstappen, L. W. M. M., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040766 · Cited by 4,593
Cell-free nucleic acids as biomarkers in cancer patients
Schwarzenbach, H., Hoon, D. S. B., & Pantel, K. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3066 · Cited by 2,891
Self-citationEMT and Dissemination Precede Pancreatic Tumor Formation
Rhim, A. D., Mirek, E. T., Aiello, N. M., Maitra, A., Bailey, J. M., McAllister, F., Reichert, M., Beatty, G. L., Rustgi, A. K., Vonderheide, R. H., et al. (2012) · Cell · doi:10.1016/j.cell.2011.11.025 · Cited by 2,136
The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers
Diaz Jr, L. A., Williams, R. T., Wu, J., Kinde, I., Hecht, J. R., Berlin, J., Allen, B., Bozic, I., Reiter, J. G., Nowak, M. A., et al. (2012) · Nature · doi:10.1038/nature11219 · Cited by 1,713
A Pooled Analysis of Bone Marrow Micrometastasis in Breast Cancer
Braun, S., Vogl, F. D., Naume, B., Janni, W., Osborne, M. P., Coombes, R. C., Schlimok, G., Diel, I. J., Gerber, B., Gebauer, G., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050434 · Cited by 1,379
Self-citationTumor Self-Seeding by Circulating Cancer Cells
Kim, M.-Y., Oskarsson, T., Acharyya, S., Nguyen, D. X., Zhang, X. H.-F., Norton, L., & Massagué, J. (2009) · Cell · doi:10.1016/j.cell.2009.11.025 · Cited by 1,335
Dissecting the metastatic cascade
Pantel, K., & Brakenhoff, R. H. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1370 · Cited by 1,281
Self-citationParallel progression of primary tumours and metastases
Klein, C. A. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2627 · Cited by 1,133
Detection, clinical relevance and specific biological properties of disseminating tumour cells
Pantel, K., Brakenhoff, R. H., & Brandt, B. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2375 · Cited by 1,118
Self-citationCirculating tumour cells in cancer patients: challenges and perspectives
Pantel, K., & Alix-Panabières, C. (2010) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.07.001 · Cited by 815
Self-citationPantel, K., Alix-Panabières, C., & Riethdorf, S. (2009) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2009.44 · Cited by 643
Self-citationRiethdorf, S., Müller, V., Zhang, L., Rau, T., Loibl, S., Komor, M., Roller, M., Huober, J., Fehm, T., Schrader, I., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2042 · Cited by 490
Self-citationCirculating Tumor Cells and Circulating Tumor DNA
Alix-Panabières, C., Schwarzenbach, H., & Pantel, K. (2012) · Annual Review of Medicine · doi:10.1146/annurev-med-062310-094219 · Cited by 485
Self-citationConsiderations in the development of circulating tumor cell technology for clinical use
Parkinson, D. R., Dracopoli, N., Petty, B. G., Compton, C., Cristofanilli, M., Deisseroth, A., Hayes, D. F., Kapke, G., Kumar, P., Lee, J. S., et al. (2012) · Journal of Translational Medicine · doi:10.1186/1479-5876-10-138 · Cited by 323
Self-citationL�cke, K. (2012) · International Journal of Oncology · doi:10.3892/ijo.2012.1557 · Cited by 314
Lianidou, E. S., & Markou, A. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2011.165068 · Cited by 265
Wülfing, P., Borchard, J., Buerger, H., Heidl, S., Zänker, K. S., Kiesel, L., & Brandt, B. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2087 · Cited by 258
Circulating Epithelial Cells in Patients with Benign Colon Diseases
Pantel, K., Denève, E., Nocca, D., Coffy, A., Vendrell, J.-P., Maudelonde, T., Riethdorf, S., & Alix-Panabières, C. (2012) · Clinical Chemistry · doi:10.1373/clinchem.2011.175570 · Cited by 255
Self-citationControversies in clinical cancer dormancy
Uhr, J. W., & Pantel, K. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1106613108 · Cited by 251
Self-citationUltrasensitive Clinical Enumeration of Rare Cells ex Vivo Using a Micro-Hall Detector
Issadore, D., Chung, J., Shao, H., Liong, M., Ghazani, A. A., Castro, C. M., Weissleder, R., & Lee, H. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003747 · Cited by 247
A Novel Platform for Detection of CK+ and CK− CTCs
Pecot, C. V., Bischoff, F. Z., Mayer, J. A., Wong, K. L., Pham, T., Bottsford-Miller, J., Stone, R. L., Lin, Y. G., Jaladurgam, P., Roh, J. W., et al. (2011) · Cancer Discovery · doi:10.1158/2159-8290.cd-11-0215 · Cited by 217
Plasticity of disseminating cancer cells in patients with epithelial malignancies
Bednarz-Knoll, N., Alix-Panabières, C., & Pantel, K. (2012) · Cancer and Metastasis Reviews · doi:10.1007/s10555-012-9370-z · Cited by 214
Self-citationAndreopoulou, E., Yang, L. ‐., Rangel, K. M., Reuben, J. M., Hsu, L., Krishnamurthy, S., Valero, V., Fritsche, H. A., & Cristofanilli, M. (2012) · International Journal of Cancer · doi:10.1002/ijc.26111 · Cited by 213
HER2-Positive Circulating Tumor Cells in Breast Cancer
Ignatiadis, M., Rothé, F., Chaboteaux, C., Durbecq, V., Rouas, G., Criscitiello, C., Metallo, J., Kheddoumi, N., Singhal, S. K., Michiels, S., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0015624 · Cited by 203
Detection and Characterization of Putative Metastatic Precursor Cells in Cancer Patients
Alix-Panabières, C., Vendrell, J.-P., Pellé, O., Rebillard, X., Riethdorf, S., Müller, V., Fabbro, M., & Pantel, K. (2007) · Clinical Chemistry · doi:10.1373/clinchem.2006.079509 · Cited by 194
Self-citationGenetic disparity between primary tumours, disseminated tumour cells, and manifest metastasis
Stoecklein, N. H., & Klein, C. A. (2010) · International Journal of Cancer · doi:10.1002/ijc.24916 · Cited by 186
Circulating Tumor Cells: Not All Detected Cells Are Bad and Not All Bad Cells Are Detected
Wicha, M. S., & Hayes, D. F. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.34.0026 · Cited by 172
EPISPOT Assay: Detection of Viable DTCs/CTCs in Solid Tumor Patients
Alix-Panabières, C. (2012) · Recent Results in Cancer Research · doi:10.1007/978-3-642-28160-0_6 · Cited by 170
Self-citationAgrawal, B., Krantz, M. J., Parker, J., et al. (1998) · PubMed · Cited by 154
Georgoulias, V., Bozionelou, V., Agelaki, S., Perraki, M., Apostolaki, S., Kallergi, G., Kalbakis, K., Xyrafas, A., & Mavroudis, D. (2012) · Annals of Oncology · doi:10.1093/annonc/mds020 · Cited by 150
Davis, J. W., Nakanishi, H., Kumar, V. S., Bhadkamkar, V. A., Mccormack, R. T., Fritsche, H. A., Handy, B. C., Gornet, T. G., & Babaian, R. J. (2008) · The Journal of Urology · doi:10.1016/j.juro.2008.01.102 · Cited by 143
Ledford, H. K. (2011) · Nature · doi:10.1038/472273a · Cited by 135
Somlo, G., Lau, S. K., Frankel, P. H., Hsieh, B. R., Liu, X., Yang, L., Krivacic, R. T., & Bruce, R. H. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1508-0 · Cited by 131
Ntouroupi, T. G., Ashraf, S. Q., McGregor, S., Turney, B. W., Seppo, A., Kim, Y., Wang, X., Kilpatrick, M. W., Tsipouras, P., Tafas, T., et al. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604545 · Cited by 128
Markou, A. N., Strati, A. D., Malamos, N., Georgoulias, V., & Lianidou, E. S. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2010.154328 · Cited by 125
Eifler, R. L., Lind, J., Falkenhagen, D., Weber, V., Fischer, M. B., & Zeillinger, R. (2010) · Cytometry Part B Clinical Cytometry · doi:10.1002/cyto.b.20560 · Cited by 80
Bednarz‐Knoll, N., Eltze, E., Semjonow, A., Rink, M., Andreas, A., Mulder, L., Hannemann, J., Fisch, M. M., Pantel, K., Weier, H. G., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0150 · Cited by 74
Self-citationLin, M. X., Hyun, K.-A., Moon, H.-S., Sim, T. S., Lee, J., Park, J. C., Lee, S. S., & Jung, H. (2012) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2012.06.016 · Cited by 51
Kim, S. J., Masago, A., Tamaki, Y., Akazawa, K., Tsukamoto, F., Sato, J., Ozawa, T., Tsujino, Y., & Noguchi, S. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1603-2 · Cited by 44
Quantitative High-Resolution Genomic Analysis of Single Cancer Cells
Hannemann, J., Meyer-Staeckling, S., Kemming, D., Alpers, I., Joosse, S. A., Pospisil, H., Kurtz, S., Görndt, J., Püschel, K., Riethdorf, S., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026362 · Cited by 35
Self-citationCirculating Tumor Cells—New Challenges Ahead
Lianidou, E. S. (2012) · Clinical Chemistry · doi:10.1373/clinchem.2011.180646 · Cited by 29
Cited by
Circulating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer Metastasis
Aceto, N., Bardia, A., Miyamoto, D. T., Donaldson, M. C., Wittner, B. S., Spencer, J. A., Yu, M., Pely, A., Engstrom, A., Zhu, H., et al. (2014) · Cell · doi:10.1016/j.cell.2014.07.013 · Cited by 2,441
Integrating liquid biopsies into the management of cancer
Siravegna, G., Marsoni, S., Siena, S., & Bardelli, A. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.14 · Cited by 1,908
Epithelial Mesenchymal Transition in Tumor Metastasis
Mittal, V. (2018) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-020117-043854 · Cited by 1,528
Cancer biomarker detection: recent achievements and challenges
Wu, L., & Qu, X. (2015) · Chemical Society Reviews · doi:10.1039/c4cs00370e · Cited by 1,214
Application of Cell-free DNA Analysis to Cancer Treatment
Corcoran, R. B., & Chabner, B. A. (2018) · New England Journal of Medicine · doi:10.1056/nejmra1706174 · Cited by 950
Metadata
- Authors
- Alix-Panabières, C., & Pantel, K.
- Venue
- Clinical Chemistry
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-01-01
- Volume
- 59
- Issue
- 1
- Pages
- 110-118
- ISSN
- 0009-9147 (ISSN-L)
- 1530-8561
- OpenAlex
- W2161661776
- Cited by
- 1,134
- References
- 43
- FWCI
- 20.74
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.